Sales and regulatory status of fixed dose combination psychotropic drugs in India: a retrospective longitudinal study-Reference-Cited by-同舟云学术

Sales and regulatory status of fixed dose combination psychotropic drugs in India: a retrospective longitudinal study

Published:2024-08-06 Issue:1 Volume:17 Page:
ISSN:2052-3211
Container-title:Journal of Pharmaceutical Policy and Practice
language:en
Short-container-title:Journal of Pharmaceutical Policy and Practice

Author:

Bogowicz Paul¹^ORCID,Mehta Aashna²^ORCID,Choudhary Shruti²^ORCID,Brhlikova Petra¹^ORCID,Roderick Peter¹^ORCID,McGettigan Patricia³^ORCID,Farooqui Habib Hasan⁴^ORCID,Sharma Aditya Narain⁵^ORCID,Pollock Allyson M.¹^ORCID

Affiliation:

1. Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UK

2. Indian Institute of Public Health – Delhi, Public Health Foundation of India, Gurugram, India

3. William Harvey Research Institute, Queen Mary University of London, London, UK

4. College of Medicine, Qatar University, Doha, Qatar

5. Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/20523211.2024.2372089

Reference53 articles.

1. AIOCD Pharmasofttech AWACS Pvt Ltd. (2011). PharmaTrac. Retrieved March 4 2024 from https://aiocdawacs.com/.

2. Clinical practice guidelines for management of depression in elderly

3. Clinical practice guidelines for the management of obsessive-compulsive disorder in children and adolescents

4. Regulatory enforcement of the marketing of fixed-dose combinations in India: a case study of systemic antibiotics

5. Central Drugs Standard Control Organization (2022a). List of approved new drugs. Retrieved March 18 2022 from https://cdsco.gov.in/opencms/opencms/en/Approval_new/Approved-New-Drugs/.